Treatment Overview

The AML treatment that a patient receives depends on a number of factors, for example, age, other medical conditions and the specific type of AML that the person is suffering from.

Patients who are “fit” (no prior significant medical conditions) and under 70 years old are usually given intravenous (IV) chemotherapy, which requires hospitalisation for 3–4 weeks. Older and more “frail” (patients with serious prior medical conditions) patients may be given different treatment options, such as subcutaneous (applied under the skin) or oral (taken by the mouth) therapies.

Watch the videos in this section to learn more about various treatment options available for AML and to gain a better understanding of how to best approach your doctors with treatment questions.

 

Videos

Genetic Subtypes for AML: How Does Mutational Status Influence Care?

How do genetic test results affect AML treatment decisions, and when is the best time for testing? Watch now to find out from leading expert Dr. Uma Borate.

Published:

Ask the AML Expert: What Do New Drugs Mean for My AML?

‘We’ve had years and years of research that we’ve been building upon to get to this point,’ says noted AML expert Dr. Daniel Pollyea. Watch this Ask the Expert replay to learn about advances for patients.

Published:

How Is the AML Treatment Landscape Evolving?

What’s happening in AML treatment research? Watch now to hear expert Dr. Thomas LeBlanc give an encouraging update on new approaches to AML treatment, genetic profiling and more.

Published:

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.

Published:

Patient Advocate Bob Klein Shares What's Ahead in Stem Cell Research and New Treatments for Chronic Illnesses

Bob Klein was inspired by his own family - wife with cancer, son with type 1 diabetes and mom with Alzheimer’s - to help others. Watch as he discusses initiatives to raise funds for stem cell research and more.

Published:

What Is the Relationship Between Emotional Stress and AML Prognosis?

Is there a connection between emotional distress and AML prognosis? Listen as Dr. Thomas LeBlanc shares findings from a recent clinical study on factors that influence treatment outcomes and patient response rates.

Published:

What Are the Current Treatment Options for AML?

During this “What Are the Current Treatment Options for AML?” full-length replay, a panel of AML experts and patients share exciting developments in treatment research and the impact on patients. Watch now to learn more.

Published:

What Emotional Side Effects Do AML Patients Face?

How does an AML diagnosis affect a person’s emotional health? Tune in as Dr. Thomas LeBlanc discusses the emotional impact of AML on patients and some commonly seen emotional responses to diagnosis and treatment.

Published:

How Can AML Patients Get Involved With Clinical Trials?

Even though U.S. clinical trial enrollment is very low, the trials bring development and new medicines to patients. Watch as Leah Szumita breaks down how patients can get involved.

Published:

Showing 9 of 61 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 6, 2019